US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist
  • 2.3460
  • -0.0640-2.66%
Trading Mar 28 10:55 ET
373.01MMarket Cap-7.82P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-55.38%-32.83M
-38.75%-9.42M
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
56.72%-21.13M
-6.79M
2.66M
-7.75M
-9.25M
Net income from continuing operations
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-600.00%-12.26M
25.88%-8.95M
30.21%-29.47M
---9.11M
---6.53M
---1.75M
---12.08M
Operating gains losses
-137.63%-791K
-338.47%-7.15M
363.00%6.48M
-95.80%38K
-124.81%-165K
117.50%2.1M
--3M
---2.47M
--905K
--665K
Depreciation and amortization
2.54%1.09M
-2.49%274K
0.00%282K
-5.17%257K
21.15%275K
19.35%1.06M
--281K
--282K
--271K
--227K
Other non cash items
68.53%3.1M
544.55%2.13M
-46.58%359K
-65.97%309K
537.14%306K
-12.51%1.84M
--330K
--672K
--908K
---70K
Change In working capital
76.84%-369K
140.75%857K
-115.06%-1.38M
118.40%1.66M
-505.93%-1.51M
32.27%-1.59M
---2.1M
--9.17M
---9.03M
--371K
-Change in receivables
-461.62%-1.65M
-183.72%-576K
-113.36%-226K
74.04%-370K
4.41%-477K
113.15%456K
--688K
--1.69M
---1.43M
---499K
-Change in prepaid assets
493.63%2.98M
176.55%1.47M
-89.79%870K
86.22%-1.3M
-41.10%1.94M
-5.64%502K
---1.92M
--8.53M
---9.4M
--3.29M
-Change in payables and accrued expense
46.98%-1.05M
118.87%137K
-105.88%-1.86M
79.60%3.49M
-23.01%-2.81M
-235.04%-1.97M
---726K
---902K
--1.94M
---2.29M
-Change in other current liabilities
-13.15%-654K
-13.33%-170K
-13.51%-168K
-11.11%-160K
-14.71%-156K
34.17%-578K
---150K
---148K
---144K
---136K
Cash from discontinued investing activities
Operating cash flow
-55.38%-32.83M
-38.75%-9.42M
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
56.72%-21.13M
---6.79M
--2.66M
---7.75M
---9.25M
Investing cash flow
Cash flow from continuing investing activities
-66.83%-699K
0
0
1K
-67.06%-700K
-121.09%-419K
0
0
0
-419K
Net intangibles purchase and sale
-66.83%-699K
--0
--0
--1K
-67.06%-700K
---419K
--0
--0
--0
---419K
Cash from discontinued investing activities
Investing cash flow
-66.83%-699K
--0
--0
--1K
-67.06%-700K
-121.09%-419K
--0
--0
--0
---419K
Financing cash flow
Cash flow from continuing financing activities
478.79%46.15M
-40K
-107.51%-594K
3,886.50%7.97M
0
7.91M
Net issuance payments of debt
--0
--0
----
----
----
---3.19M
--0
----
----
----
Net common stock issuance
305.00%47M
--0
--0
----
----
--11.61M
--0
--11.61M
----
----
Net other financing activities
-92.12%-853K
---40K
-16.24%-594K
----
----
-322.00%-444K
--0
---511K
----
----
Cash from discontinued financing activities
Financing cash flow
478.79%46.15M
---40K
-107.51%-594K
----
----
3,886.50%7.97M
--0
--7.91M
----
----
Net cash flow
Beginning cash position
-15.78%57.42M
28.78%80.52M
65.07%87.43M
-18.64%48.66M
-15.78%57.42M
-46.48%68.18M
--62.53M
--52.97M
--59.81M
--68.18M
Current changes in cash
192.89%12.61M
-39.32%-9.46M
-176.79%-8.11M
605.76%38.88M
10.10%-8.69M
70.88%-13.58M
---6.79M
--10.57M
---7.69M
---9.67M
Effect of exchange rate changes
-108.27%-233K
-174.91%-1.26M
220.04%1.2M
-112.65%-107K
-105.41%-70K
122.40%2.82M
--1.68M
---1M
--846K
--1.29M
End cash Position
21.56%69.8M
21.56%69.8M
28.78%80.52M
65.07%87.43M
-18.64%48.66M
-15.78%57.42M
--57.42M
--62.53M
--52.97M
--59.81M
Free cash flow
-55.60%-33.53M
-38.75%-9.42M
-382.78%-7.52M
-1.92%-7.9M
10.10%-8.69M
55.87%-21.55M
---6.79M
--2.66M
---7.75M
---9.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -55.38%-32.83M-38.75%-9.42M-382.78%-7.52M-1.93%-7.9M13.59%-7.99M56.72%-21.13M-6.79M2.66M-7.75M-9.25M
Net income from continuing operations -46.79%-43.25M22.65%-7.05M-129.69%-15M-600.00%-12.26M25.88%-8.95M30.21%-29.47M---9.11M---6.53M---1.75M---12.08M
Operating gains losses -137.63%-791K-338.47%-7.15M363.00%6.48M-95.80%38K-124.81%-165K117.50%2.1M--3M---2.47M--905K--665K
Depreciation and amortization 2.54%1.09M-2.49%274K0.00%282K-5.17%257K21.15%275K19.35%1.06M--281K--282K--271K--227K
Other non cash items 68.53%3.1M544.55%2.13M-46.58%359K-65.97%309K537.14%306K-12.51%1.84M--330K--672K--908K---70K
Change In working capital 76.84%-369K140.75%857K-115.06%-1.38M118.40%1.66M-505.93%-1.51M32.27%-1.59M---2.1M--9.17M---9.03M--371K
-Change in receivables -461.62%-1.65M-183.72%-576K-113.36%-226K74.04%-370K4.41%-477K113.15%456K--688K--1.69M---1.43M---499K
-Change in prepaid assets 493.63%2.98M176.55%1.47M-89.79%870K86.22%-1.3M-41.10%1.94M-5.64%502K---1.92M--8.53M---9.4M--3.29M
-Change in payables and accrued expense 46.98%-1.05M118.87%137K-105.88%-1.86M79.60%3.49M-23.01%-2.81M-235.04%-1.97M---726K---902K--1.94M---2.29M
-Change in other current liabilities -13.15%-654K-13.33%-170K-13.51%-168K-11.11%-160K-14.71%-156K34.17%-578K---150K---148K---144K---136K
Cash from discontinued investing activities
Operating cash flow -55.38%-32.83M-38.75%-9.42M-382.78%-7.52M-1.93%-7.9M13.59%-7.99M56.72%-21.13M---6.79M--2.66M---7.75M---9.25M
Investing cash flow
Cash flow from continuing investing activities -66.83%-699K001K-67.06%-700K-121.09%-419K000-419K
Net intangibles purchase and sale -66.83%-699K--0--0--1K-67.06%-700K---419K--0--0--0---419K
Cash from discontinued investing activities
Investing cash flow -66.83%-699K--0--0--1K-67.06%-700K-121.09%-419K--0--0--0---419K
Financing cash flow
Cash flow from continuing financing activities 478.79%46.15M-40K-107.51%-594K3,886.50%7.97M07.91M
Net issuance payments of debt --0--0---------------3.19M--0------------
Net common stock issuance 305.00%47M--0--0----------11.61M--0--11.61M--------
Net other financing activities -92.12%-853K---40K-16.24%-594K---------322.00%-444K--0---511K--------
Cash from discontinued financing activities
Financing cash flow 478.79%46.15M---40K-107.51%-594K--------3,886.50%7.97M--0--7.91M--------
Net cash flow
Beginning cash position -15.78%57.42M28.78%80.52M65.07%87.43M-18.64%48.66M-15.78%57.42M-46.48%68.18M--62.53M--52.97M--59.81M--68.18M
Current changes in cash 192.89%12.61M-39.32%-9.46M-176.79%-8.11M605.76%38.88M10.10%-8.69M70.88%-13.58M---6.79M--10.57M---7.69M---9.67M
Effect of exchange rate changes -108.27%-233K-174.91%-1.26M220.04%1.2M-112.65%-107K-105.41%-70K122.40%2.82M--1.68M---1M--846K--1.29M
End cash Position 21.56%69.8M21.56%69.8M28.78%80.52M65.07%87.43M-18.64%48.66M-15.78%57.42M--57.42M--62.53M--52.97M--59.81M
Free cash flow -55.60%-33.53M-38.75%-9.42M-382.78%-7.52M-1.92%-7.9M10.10%-8.69M55.87%-21.55M---6.79M--2.66M---7.75M---9.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
-0.77%
Vale SA
VALE
-1.23%
Petroleo Brasileiro SA Petrobras
PBR
-1.25%
NVIDIA
NVDA
-1.57%
Apple
AAPL
-1.59%

Unlock the Full List